Trials / Conditions / Convalescent Plasma
Convalescent Plasma
6 registered clinical trials studyying Convalescent Plasma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Convalescent Plasma Therapy for Hospitalized Patients With COVID-19 NCT05077930 | Tânia Portella Costa | Phase 2 |
| Completed | COVID-19 Infection in Patients Receiving Anti-CD20 Therapy NCT04884477 | Mayo Clinic | — |
| Unknown | Statistical and Epidemiological Study Based on the Use of Convalescent Plasma for the Management of Patients W NCT04452812 | Universidad Autonoma de Coahuila | Phase 1 / Phase 2 |
| Completed | A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection NCT04392232 | TriHealth Inc. | Phase 2 |
| Completed | Efficacy and Safety of COVID-19 Convalescent Plasma NCT04397523 | Institute for Transfusion Medicine of RNM | N/A |
| Completed | Clinical Efficacy of Early Administration of Convalescent Plasma Among COVID-19 Cases in Egypt NCT04816942 | Ministry of Health and Population, Egypt | Phase 3 |